Trading Signals: AUTL Stock Price Prediction and Forecast (Fri. Jun. 22, 2018 - Fri. May. 13, 2022)(Autolus Therapeutics plc )
| AUTL latest price $5.8600 (1.74%) ($5.8600 - $5.8600) on Thu. Apr. 1, 2021. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 4.11% (three month average) | RSI | 38 | Latest Price | $5.8600(1.74%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | AUTL declines -0.9% a day on average for past five trading days. | Weekly Trend | AUTL declines -7.9% a week on average for past two weeks. | Market Behavior | Broad based rally for large cap. Broad based rally for small cap. | Correlated ETFs | Broad market will support AUTL advance at 0% a week (0% probability) BNDX(11%) TLT(10%) SKYY(9%) BND(8%) LIT(8%) | Factors Impacting AUTL price | AUTL will decline at least -2.055% in a week (0% probabilities). TBT(-9%) USO(-7%) UNG(-7%) XLF(-4%) XLB(-3%) | | | | | Relative Volatility | | | | Market Trend Strength | -2.055% (StdDev 4.11%) | Hourly BBV | 0.7 () | Intraday Trend | 0% | | | |
|
1 - 5 Day Possible Target | $-6.55(-211.77%) | Inflection Point | Yes | Resistance Level | $6.29 | 5 Day Moving Average | $5.75(1.91%) | 10 Day Moving Average | $6.04(-2.98%) | 20 Day Moving Average | $6.29(-6.84%) | To recent high | -37.6% | To recent low | 6.7% | Market Cap | $306m | | | | Autolus Therapeutics Plc is a biopharmaceutical company. It engages in the development of cancer treatments. The firm's portfolio includes B Cell Malignancies, Multiple Myeloma, T Cell Lymphoma, GD2+ Tumors, and Prostate Cancer. The company was founded by Martin Pulé in February 2018 and is headquartered in London, the United Kingdom. |